This inventor holds 7 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Bristol-Myers Squibb Compnay, B. Braun Medical Inc., Eli Lilly and Company. Active years: 2020-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Bethlehem, PA (US) (2020 - 2024)
- Baltimore, MD (US) (2022 - 2024)
Company Filing History:



Years Active: 2020-2025
Title: Innovations by Jeffrey Manfred Gunnarsson
Introduction
Jeffrey Manfred Gunnarsson is a notable inventor based in Bethlehem, PA, with a significant contribution to the field of drug delivery systems. He holds a total of seven patents, showcasing his innovative approach to enhancing medication accuracy and delivery.
Latest Patents
Among his latest patents is a "System for interrogating serially-connected drug modules in a combinatorial drug delivery device." This invention includes a plurality of serially connectable modules, each containing at least one drug component, and a master controller with a computing processing unit. The system is designed to confirm the accuracy of drugs provided with the device and ensure the correct sequencing of medication. Another significant patent is the "Medication error detection system," which checks the proper inclusion and sequencing of drug modules in a combinatorial drug delivery device.
Career Highlights
Throughout his career, Gunnarsson has worked with prominent companies such as Bristol-Myers Squibb Company and B. Braun Medical Inc. His experience in these organizations has contributed to his expertise in developing advanced drug delivery technologies.
Collaborations
Gunnarsson has collaborated with notable individuals in his field, including Aaron Samuel Pearl and Mariano Mumpower. Their joint efforts have likely played a role in the successful development of his innovative patents.
Conclusion
Jeffrey Manfred Gunnarsson's contributions to drug delivery systems through his patents reflect his commitment to improving medication accuracy and safety. His work continues to influence the field of pharmaceutical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile